Szarkóma: vizsgálatok itt: Szingapúr
5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 405 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06884618 · EU 2024-519622-20-00 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Singapore
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleUsing QPOP to Predict Treatment for Sarcomas and Melanomas
- Where
- Singapore
- Életkor
- 21 év to 99 év
- People
- 100
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT04986748